Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

PURPOSE: In advanced urothelial cancer, treatment with dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) results in a high response rate, less toxicity, and few dosing delays. We explored the efficacy and safety of neoadjuvant ddMVAC with pegfilgrastim support in muscle-invas...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Oncol
Главные авторы: Choueiri, Toni K., Jacobus, Susanna, Bellmunt, Joaquim, Qu, Angela, Appleman, Leonard J., Tretter, Christopher, Bubley, Glenn J., Stack, Edward C., Signoretti, Sabina, Walsh, Meghara, Steele, Graeme, Hirsch, Michelle, Sweeney, Christopher J., Taplin, Mary-Ellen, Kibel, Adam S., Krajewski, Katherine M., Kantoff, Philip W., Ross, Robert W., Rosenberg, Jonathan E.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Clinical Oncology 2014
Предметы:
ORIGINAL REPORTS
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057274/
https://ncbi.nlm.nih.gov/pubmed/24821883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.52.4785
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы